Type 2 diabetes and the metabolic syndrome in children and adolescents.

Curr Diab Rep

Pfizer Global Pharmaceuticals, Pfizer, Inc., 235 East 42 Street, New York, NY 10017, USA.

Published: June 2006

The prevalence rates of obesity, metabolic syndrome, and type 2 diabetes in children are increasing at an alarming rate. The potential impact of these conditions on the individual, the family, and society, especially in regard to the costs and utilization of health care resources, are very serious. Strategies aimed at reducing caloric intake, increasing caloric expenditure through regular exercise, and treating cardiovascular risk factors and type 2 diabetes early and aggressively are necessary to meet the challenges they impose.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-006-0041-8DOI Listing

Publication Analysis

Top Keywords

type diabetes
12
metabolic syndrome
8
diabetes metabolic
4
syndrome children
4
children adolescents
4
adolescents prevalence
4
prevalence rates
4
rates obesity
4
obesity metabolic
4
syndrome type
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!